insights_auto
Why is ALK-B down 2.37%?
Dive Deeperchevron_right
ALK-B:CPH
ALK-Abello A/S
DKK 239.20
arrow_downward
-2.37%(-5.80) 1D
ኖቬም 20, 5:00:00 ከሰዓት ጂ ኤም ቲ+1 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALK-B...
Open
DKK 243.80
High
DKK 244.00
Low
DKK 238.60
Mkt. cap
48.45 ቢ
Avg. vol.
203.93 ሺ
Volume
185.88 ሺ
52-wk high
DKK 271.40
52-wk low
DKK 191.80
Shares outstanding
202.57 ሚ
No. of employees
3 ሺ
Open
DKK 243.80
High
DKK 244.00
Low
DKK 238.60
Mkt. cap
48.45 ቢ
Avg. vol.
203.93 ሺ
Volume
185.88 ሺ
52-wk high
DKK 271.40
52-wk low
DKK 191.80
Shares outstanding
202.57 ሚ
No. of employees
3 ሺ
News stories
From web sources and news partners
AP News
·
ከ16 ሰዓቶች በፊት
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Trefis
·
ከ7 ሰዓቶች በፊት
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
24/7 Wall St.
·
ከ19 ደቂቃዎች በፊት
Wall Street's Fear Index Just Hit 9.7. History Says the S&P 500 Could Rally 10.5% in 3 Weeks
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter Halling
Employees2.8 ሺ
Founded1923
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealk.net